1Coleman RE.Skeletal complications of malignancy[J].Cancer,1997;80:1588-94. 被引量：1
2Saad F,Olsson C,Schulman CC.Skeletal morbidity in men with prostate cancer:quality-of-life considerations throughout the continous of care[J].Eur Urol,2004;46:731-9. 被引量：1
3Costa L,Lipton A,Coleman RE.Role of bisphosphonates for the management of skeletal complications and bone pain from skeletal metastases[J].Support Cancer Ther,2006;3:143-53. 被引量：1
4Kakonen SM,Mundy GR.Mechanisms of osteolytic bone metastases in breast carcinoma[J].Cancer,2003;97:834-9. 被引量：1
5Fleisch H.Development of bisphosphonates[J].Breast Cancer Res,2002;4:30-4. 被引量：1
7Boissier S,Ferreras M,Peyruchaud O,et al.Bisphosphonates inhibit breast and prostate carcinoma cell invasion,an early event in the formation of bone metastases[J].Cancer Res,2000;60:2949-54. 被引量：1
8Fournier P,Boissier S,Filleur S,et al.Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats[J].Cancer Res,2002;62:6538-44. 被引量：1
9Gralow J,Tripathy D.Managing metastatic bone pain:the role of bisphosphonates[J].J Pain Symptom Manage,2007;33:462-72. 被引量：1
10Thomas JP,Vladimir M.Zoledronic acid in the management of metastatic bone disease[J].Ther Clin Risk Manag,2008;4:261-8. 被引量：1
4Thomas JP,Vladimir M.Zoledronic acid in the management of metastatic bone disease[J].Ther Clin Risk Manag,2008,4(2):261-268. 被引量：1
5KHANDURI A C, STATHOPOULOS T, BEDARD C. Wind-induced interference effects on buildings - a review of the state-of-the-art [ J ]. Engineering Struc- tures, 1998,20(7) :617-630. 被引量：4
6Reale C,Turkiewicz A M,Reale C A.Antalgic treatment of pain associated with bone metastases[J].Crit Rev Oncol Hematol,2001,37:1-11. 被引量：1
7Amichetti M,Orru P,Madeddu A,et al.Comparative evaluation of two hypofractionated radiotherapy regimens for painful bone metastases[J].Tumori,2004,90:91-95. 被引量：1
8Fitch M, Maxwell C, Ryan C,et al. Bone metastases from advanced cancers : Clinical implication and treatment options[J]. Clin J Oncol Nurs,2009,13(6) :701 - 710. 被引量：1
9Pase FM, Serafini AN. Syetemic metabolic radiopharmaceutical therapy in treatment of metastatic bone pain[J]. Semin Nucl Med, 2010,40(2) :89 - 104. 被引量：1
10Neville- Webbe HL, Coleman RE. Bisphonates and RANK ligandinhibitors for the treatment and prevention of metastatic bone dis- ease[J. Eur J Cancer,2010,26(7) :1211 - 1222. 被引量：1
